Search results

Jump to navigation Jump to search
  • ...h an interest in clinical cytogenetics, molecular genetics and genomics in cancer. [[Contact us]] for more information.''' [[File:Circos.png|100px|link=Main_Page]] '''Cancer Genomes''' [[Hematologoic and Lymphoid]] | [[Solid Tumors]] | [[CNS]] | [[P
    7 KB (905 words) - 03:59, 21 November 2017
  • ...h an interest in clinical cytogenetics, molecular genetics and genomics in cancer. [[Contact us]] for more information and meet our editorial [[Leadership]]. [[File:Circos.png|100px|link=Main_Page]] '''Cancer Genomes''' [[Hematologic and Lymphoid]] | [[Solid Tumors]] | [[CNS]] | [[Pe
    8 KB (1,008 words) - 23:03, 6 August 2020
  • == Genes == * Cancer Genes A
    10 KB (1,089 words) - 03:30, 21 November 2017
  • ...es S]] [[Category:Diseases T]] [[Category:Diseases U]] [[Category:Diseases V]] [[Category:Diseases W]] [[Category:Diseases X]] [[Category:Diseases Y]] [
    14 KB (1,459 words) - 03:32, 21 November 2017
  • ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
    10 KB (1,375 words) - 18:17, 2 January 2020
  • == Genes Involved == ...t and t(14;19)(q32;q13) in lymphoproliferative disorders. Genes Chromosome Cancer 15:38–47CrossRef
    4 KB (537 words) - 02:44, 21 July 2016
  • ==General Disease Overview / Description of Cancer Category== *[[B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged]]
    2 KB (290 words) - 01:10, 6 May 2020
  • ==General Disease Overview / Description of Cancer Category== - [[B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged]]
    3 KB (317 words) - 17:27, 27 May 2020
  • "KIT Proto-Oncogene Receptor Tyrosine Kinase"; "V-Kit Hardy-Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog"; PBT; "Stem C ==Cancer Category/Type==
    7 KB (1,046 words) - 18:50, 1 October 2018
  • ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
    9 KB (1,310 words) - 16:57, 29 September 2020
  • ...>Diaz JI, Mora LB, Hakam A. The Mainz Classification of Renal Cell Tumors. Cancer Control. 1999 Nov;6(6):571-579</ref> ...ton CJ. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014 Sep 8;26(3):319-30.</ref>
    3 KB (421 words) - 16:29, 22 August 2016
  • ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
    10 KB (1,400 words) - 19:11, 22 June 2020
  • .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)
    23 KB (3,285 words) - 21:56, 8 August 2020
  • .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)
    23 KB (3,285 words) - 20:49, 13 September 2019
  • .... Table derived from Xu et al., 2018 [PMID 30344013] with permission from Cancer Genetics. !Relevant Genes (if known)
    23 KB (3,282 words) - 16:49, 14 June 2019
  • ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
    9 KB (1,320 words) - 16:52, 2 August 2020
  • ==Cancer Category/Type== ==Cancer Sub-Classification / Subtype==
    10 KB (1,340 words) - 22:53, 14 September 2020
  • ...Table derived from Pugh et al., 2018 [PMID 30393007] with permission from Cancer Genetics. |'''Genes'''
    17 KB (2,298 words) - 03:28, 8 November 2020
  • ==Cancer Category/Type== ...scular endothelial growth factor (''VEGF'') (Merdzhanova et al., 2010). In cancer, ''SRSF2'' variants have been implicated in leukemia and myeloid disorders
    16 KB (2,279 words) - 04:00, 5 September 2018
  • Thank you for volunteering to help curate the Compendium of Cancer Genome Aberrations (CCGA)! Your help will make this resource a valuable to ...“Disease pages”. The CCGA is especially interested in the curation fusion genes/mutations that arise in disease, esp. in the hematological cancers. Howeve
    7 KB (1,171 words) - 22:30, 23 April 2019

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)